Leap Therapeutics, Inc.Leap Therapeutics, Inc.Leap Therapeutics, Inc.

Leap Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪75.79 M‬USD
−5.12USD
‪−81.41 M‬USD
‪23.43 M‬
Beta (1Y)
3.96

About Leap Therapeutics, Inc.

CEO
Doug E. Onsi
Website
Headquarters
Cambridge
Employees (FY)
54
Founded
2011
ISIN
US52187K2006
FIGI
BBG00DQ929W6
Leap Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies designed to treat patients with cancer. The company was founded on January 3, 2011 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LPTX is 2.84 USD — it has decreased by 4.05% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Leap Therapeutics, Inc. stocks are traded under the ticker LPTX.
Leap Therapeutics, Inc. is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
LPTX stock is 9.75% volatile and has beta coefficient of 3.96. Check out the list of the most volatile stocks — is Leap Therapeutics, Inc. there?
One year price forecast for Leap Therapeutics, Inc. has a max estimate of 16.00 USD and a min estimate of 7.00 USD.
LPTX earnings for the last quarter are −0.51 USD per share, whereas the estimation was −0.58 USD resulting in a 11.76% surprise. The estimated earnings for the next quarter are −0.54 USD per share. See more details about Leap Therapeutics, Inc. earnings.
Leap Therapeutics, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach ‪1.50 M‬ USD.
Yes, you can track Leap Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
LPTX stock has fallen by 9.84% compared to the previous week, the month change is a 28.51% rise, over the last year Leap Therapeutics, Inc. has showed a 21.11% decrease.
LPTX net income for the last quarter is ‪−12.47 M‬ USD, while the quarter before that showed ‪−13.70 M‬ USD of net income which accounts for 8.99% change. Track more Leap Therapeutics, Inc. financial stats to get the full picture.
Today Leap Therapeutics, Inc. has the market capitalization of ‪75.79 M‬, it has decreased by 1.90% over the last week.
No, LPTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, LPTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Leap Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
LPTX reached its all-time high on Apr 12, 2018 with the price of 102.50 USD, and its all-time low was 1.24 USD and was reached on Oct 2, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 54.00 employees. See our rating of the largest employees — is Leap Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Leap Therapeutics, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Leap Therapeutics, Inc. stock shows the sell signal. See more of Leap Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Leap Therapeutics, Inc. future price: according to them, LPTX price has a max estimate of 16.00 USD and a min estimate of 7.00 USD. Read a more detailed Leap Therapeutics, Inc. forecast: see what analysts think of Leap Therapeutics, Inc. and suggest that you do with its stocks.